Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)

NCT00872950 ·Status: APPROVED_FOR_MARKETING

3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)

NCT02012933 ·Status: NO_LONGER_AVAILABLE

Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

NCT01378546 ·Status: NO_LONGER_AVAILABLE

Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome

NCT01373333 ·Status: NO_LONGER_AVAILABLE

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

NCT02970162 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

NCT01377922 ·Status: COMPLETED ·Phase: PHASE3

Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome

NCT02189720 ·Status: APPROVED_FOR_MARKETING

Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia

NCT03062631 ·Status: NO_LONGER_AVAILABLE

Treatment Use of 3,4-Diaminopyridine

NCT01765140 ·Status: NO_LONGER_AVAILABLE

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

NCT02562066 ·Status: COMPLETED ·Phase: PHASE3

4-Aminopyridine in Episodic Ataxia Type 2

NCT01543750 ·Status: WITHDRAWN ·Phase: PHASE2

An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders

NCT04616807 ·Status: ACTIVE_NOT_RECRUITING

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

NCT05544058 ·Status: COMPLETED

Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)

NCT02045667 ·Status: COMPLETED ·Phase: PHASE2

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

NCT01645787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

NCT01468350 ·Status: COMPLETED ·Phase: PHASE1

Study of NMDA Antagonists and Neuropathic Pain

NCT01602185 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT04944784 ·Status: TERMINATED ·Phase: PHASE3

Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients

NCT02015481 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I

NCT00439218 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Ephedrine for the Treatment of Congenital Myasthenia

NCT00541216 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke

NCT01605825 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2

NCT04700046 ·Status: WITHDRAWN ·Phase: PHASE3

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

NCT01498120 ·Status: COMPLETED ·Phase: PHASE2

Mecamylamine for Autonomic Dysreflexia Prophylaxis

NCT03914677 ·Status: UNKNOWN ·Phase: PHASE4